In the highly competitive pharmaceutical industry, companies must carefully navigate the complex regulatory landscape when promoting their products. A recent case ruling by the Prescription Medicines Code of Practice Authority (PMCPA) highlights the importance of ensuring promotional claims are accurate, balanced and supported by robust evidence.
![The Importance of Accurate and Balanced Promotional Claims: Lessons from the PMCPA Trelegy Case](https://darkdrug.com/wp-content/uploads/2024/06/AdobeStock_828914057-1080x675.jpeg)